isoniazid has been researched along with thiolactomycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, NP; Dick, JD; Houston, TA; Jones, PB; Parrish, NM; Stapon, A; Townsend, CA | 1 |
| Chibale, K; Franzblau, SG; Gut, J; Hans, RH; Rosenthal, PJ; van Helden, PD; Wan, B; Wiid, IJ | 1 |
| Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV | 1 |
| Bera, S; Mondal, D | 1 |
| Barry, CE; Lee, RE; Slayden, RA | 1 |
| Barry, CE; Slayden, RA | 1 |
| Betts, JC; Blakemore, SJ; Duncan, K; Kelly, FM; Lennon, MG; Lukey, PT; McLaren, A | 1 |
| Azeeza, S; Kamal, A; Malik, MS; Rao, MV; Shaik, AA | 1 |
2 review(s) available for isoniazid and thiolactomycin
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.
Topics: Animals; Antitubercular Agents; Drug Design; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Physiological Phenomena; Pyrazinamide; Rifamycins; Streptomycin; Thiophenes; Tuberculosis; Tuberculosis, Pulmonary | 2008 |
6 other study(ies) available for isoniazid and thiolactomycin
| Article | Year |
|---|---|
A new class of antituberculosis agents.
Topics: Amides; Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfones | 2000 |
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Isatin; Lactones; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship | 2011 |
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Acetyltransferases; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Microbial; Enzyme Inhibitors; Fatty Acid Synthase, Type II; Humans; Isoniazid; Lipids; Microbial Sensitivity Tests; Multienzyme Complexes; Mycobacterium smegmatis; Mycobacterium tuberculosis; Operon; Oxidoreductases; Thiophenes; Triclosan | 2000 |
The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Antibiotics, Antitubercular; Cell-Free System; Culture Media; Drug Resistance, Bacterial; Fatty Acid Synthases; Isoniazid; Mutation; Mycobacterium smegmatis; Mycobacterium tuberculosis; Mycolic Acids; Substrate Specificity; Thiophenes; Triclosan | 2002 |
Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antitubercular Agents; DNA, Complementary; Down-Regulation; Gene Expression Regulation, Bacterial; Isoniazid; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Operon; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial; Thiophenes; Triclosan; Up-Regulation | 2003 |